Discover how artificial intelligence will impact the radiology field, creating new growth opportunities.
Top Artificial Intelligence Trends Influencing the Future of Radiology
Given the pace of technology advancement, artificial intelligence (AI) in radiology has moved past the nascent stage toward maturity. Commercial adoption is on the rise, while the industry continues to see an increasing number of startups emerging to serve radiology AI needs. However, the market is fundamentally different today than before the pandemic. Here are the top trends in radiology AI that all market stakeholders should consider.
Comprehensive End-to-end, Value-adding Solutions
Gone are the days of developing a simple reading room solution that assists radiologists in identifying areas of interest. Solutions that support the full care continuum for current disease conditions are more likely to gain a foothold. These solutions will suggest the best imaging tests to be performed based on symptoms and the optimal scan settings to obtain the necessary images. They will guide clinicians in making the appropriate diagnosis and treatment decisions.
RapidAI - Beyond stroke detection, this workflow solution helps in-app communication with stroke team members to assemble an interventional team at a moment's notice, reducing the time from detection to intervention.
VIDA - In pulmonology, VIDA Insights (erstwhile LungPrint) helps with early disease detection, optimizes the interpretation time of complex conditions like COPD and ILD, and helps make the right treatment decisions.
Multiple Anomaly Detection Solutions
Care providers increasingly prefer solutions that can detect multiple anomalies in a single scan, which can reduce image reading time and minimize human error. These solutions could be valuable in emergency trauma cases, where an incidental finding could help save a life. Although this is notably a smaller trend, such solutions are perceived to provide a higher return on investment. One example is Annalise.AI, which can detect over 120 abnormalities in a chest X-ray.
Risk-based Screening Stratification Solutions
Artificial intelligence solutions designed to help reduce the volume of scans by 'weeding out' normal patients and flagging abnormal ones for radiologist review are becoming increasingly popular. Recent evidence presented at radiology conferences points to how these solutions can significantly reduce the radiologist's workload, especially with mammography screening (in developed countries) and tuberculosis screening (in developing countries), which typically see large volumes of scans. These solutions also help prevent, or at least reduce, unnecessary diagnostic testing such as biopsies and associated costs.
Demand for Radiology AI Solutions
APAC Warming Up to Radiology AI
There is a marked increase in radiology AI adoption among emerging markets, especially in the APAC region. Care providers are procuring solutions from local vendors, like Synapsica.AI and Rises.AI in
Self-developed AI Solutions Remain in Demand
Despite many artificial intelligence solution vendors out there, the demand from hospitals to develop their own AI solutions persists. Some vendors also help in this regard;
Platforms and Marketplaces Grow but Face Lukewarm Response
Since 2017, several companies have established an AI marketplace offering a gamut of AI services from a variety of vendors. Blackford Analysis,
However, this approach still faces adoption barriers, leading key players to shift to a platform model, which offers end-users a host of value-add solutions to help manage administrative and operational processes along with their imaging workflows. These are better positioned to demonstrate higher value and ROI, but only time will tell if this approach sways radiology departments and hospital CFOs in its favor. Philips (HealthSuite) and
Interesting Vendor Shifts and Dynamics
Novel Partnerships
Over the past five years, the evolving complexity of radiology AI and its commercial ecosystem has shown that no solution provider can succeed alone. Emerging use cases and intense competition will force unprecedented partnerships among AI solutions providers in their pursuit to capture market share. Partnerships can range from basic integrations (ScImage and DiA Imaging Analysis for viewer integration), distribution (Fujifilm X-ray with Annalise.AI), and R&D (
New Players' Entry Somewhat Balanced by Consolidation
The competitive landscape is currently witnessing interesting developments. On the one hand, a host of new vendors like Artyra, Mireye, and Vinbrain have entered the fray, especially from emerging markets. On the other, a few key players like
Interestingly, a few companies have exited the space altogether. MaxQ.AI pivoted into other businesses, whereas
Growth Barriers: Reimbursements, Funding & IPOs
The broader barrier to adopting the reimbursement model has not been addressed, even in developed markets. The market saw no major developments beyond the 'NTAP' payments for Stroke AI, which caused quite a flutter.
The sector is also witnessing an uneven funding pattern and a significant drop in the number of deals being made, potentially fueled by the global economic slowdown. Pre-pandemic times saw an equitable distribution of funding across all kinds and stages of AI startups. Now, only a few big players like Viz.AI and Aidoc are snagging lucrative deals, while smaller vendors are receiving much lower amounts. However,
Conclusion
Massive strides in computer technology have helped artificial intelligence make serious inroads in the field of radiology. These developments are worth noting for radiology stakeholders and the broader healthcare space in general as AI continues to redefine care delivery with more companies constantly pushing the boundaries of what's possible. We believe the next three years will see radical changes to this space, and we'll closely track.
To discover more about the latest trends for this market and learn how
About
For six decades,
(C) 2022 Electronic News Publishing, source